Ghost Tree Capital as of Sept. 30, 2014
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 70 positions in its portfolio as reported in the September 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Bristol-myers Squibb | 5.6 | $10M | 200k | 51.18 | |
VALEANT PHARMACEUTICALS Inte call | 3.6 | $6.6M | 50k | 131.20 | |
Abbvie | 3.1 | $5.8M | 100k | 57.76 | |
Agilent Technologies Inc call | 3.1 | $5.7M | 100k | 56.98 | |
Community Health Systems (CYH) | 3.0 | $5.5M | 100k | 54.79 | |
Horizon Pharma | 2.8 | $5.2M | 425k | 12.28 | |
Zimmer Holdings (ZBH) | 2.7 | $5.0M | 50k | 100.56 | |
Tornier Nv | 2.6 | $4.8M | 200k | 23.90 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.4 | $4.5M | 40k | 112.30 | |
Allergan | 2.4 | $4.5M | 25k | 178.20 | |
Cepheid Inc cmn | 2.4 | $4.4M | 100k | 44.03 | |
Hca Holdings (HCA) | 2.3 | $4.2M | 60k | 70.52 | |
Mallinckrodt Pub | 2.2 | $4.1M | 45k | 90.16 | |
Zeltiq Aesthetics | 2.1 | $4.0M | 175k | 22.63 | |
Intuitive Surgical (ISRG) | 2.1 | $3.9M | 8.5k | 461.76 | |
Cyberonics | 2.1 | $3.8M | 75k | 51.16 | |
Ariad Pharmaceuticals | 2.0 | $3.8M | 700k | 5.40 | |
Thoratec Corporation | 2.0 | $3.7M | 140k | 26.73 | |
AtriCure (ATRC) | 2.0 | $3.7M | 250k | 14.72 | |
Accuray Inc Del note 3.750% 8/0 | 2.0 | $3.6M | 500k | 7.26 | |
Actavis | 2.0 | $3.6M | 15k | 241.27 | |
Concert Pharmaceuticals I equity | 1.9 | $3.5M | 281k | 12.61 | |
Therapeuticsmd | 1.9 | $3.5M | 750k | 4.64 | |
Envision Healthcare Hlds | 1.9 | $3.5M | 100k | 34.68 | |
Zs Pharma | 1.8 | $3.3M | 85k | 39.24 | |
Valeant Pharmaceuticals Int | 1.8 | $3.3M | 25k | 131.20 | |
NEUROCRINE BIOSCIENCES INC CMN Stock cmn | 1.7 | $3.1M | 200k | 15.67 | |
Clovis Oncology | 1.6 | $2.9M | 65k | 45.35 | |
Portola Pharmaceuticals | 1.6 | $2.9M | 115k | 25.28 | |
Gw Pharmaceuticals Plc ads | 1.5 | $2.8M | 35k | 80.86 | |
Alnylam Pharmaceuticals (ALNY) | 1.5 | $2.7M | 35k | 78.11 | |
Quidel Corporation | 1.5 | $2.7M | 100k | 26.87 | |
Spectranetics Corporation | 1.4 | $2.7M | 100k | 26.57 | |
Bruker Corporation (BRKR) | 1.4 | $2.6M | 140k | 18.51 | |
Edwards Lifesciences (EW) | 1.4 | $2.6M | 25k | 102.16 | |
EXACT Sciences Corporation (EXAS) | 1.3 | $2.4M | 125k | 19.38 | |
Chimerix (CMRX) | 1.2 | $2.2M | 81k | 27.61 | |
Ptc Therapeutics I (PTCT) | 1.2 | $2.2M | 50k | 44.02 | |
Aegerion Pharmaceuticals | 1.1 | $2.0M | 60k | 33.38 | |
Antares Pharma | 1.1 | $2.0M | 1.1M | 1.83 | |
Medtronic | 1.0 | $1.9M | 30k | 61.97 | |
DepoMed | 1.0 | $1.8M | 120k | 15.19 | |
Tandem Diabetes Care | 1.0 | $1.8M | 132k | 13.42 | |
NuVasive | 0.9 | $1.7M | 50k | 34.88 | |
Avalanche Biotechnologies In | 0.9 | $1.7M | 50k | 34.20 | |
Neurocrine Biosciences (NBIX) | 0.8 | $1.6M | 100k | 15.67 | |
Achillion Pharmaceuticals In cmn | 0.8 | $1.5M | 150k | 9.98 | |
Zafgen | 0.8 | $1.5M | 75k | 19.65 | |
Enanta Pharmaceuticals (ENTA) | 0.8 | $1.4M | 35k | 39.57 | |
Oncothyreon | 0.7 | $1.3M | 700k | 1.92 | |
Smith & Nephew (SNN) | 0.7 | $1.3M | 15k | 84.20 | |
Bluebird Bio (BLUE) | 0.7 | $1.3M | 35k | 35.89 | |
Agios Pharmaceuticals (AGIO) | 0.7 | $1.2M | 20k | 61.35 | |
Puma Biotechnology (PBYI) | 0.7 | $1.2M | 5.0k | 238.60 | |
Alimera Sciences | 0.6 | $1.1M | 200k | 5.42 | |
Vanda Pharmaceuticals | 0.6 | $1.0M | 100k | 10.38 | |
Nanostring Technologies (NSTGQ) | 0.5 | $985k | 90k | 10.94 | |
Alcobra | 0.4 | $772k | 50k | 15.44 | |
Biolase Technology | 0.4 | $747k | 300k | 2.49 | |
Receptos | 0.4 | $764k | 12k | 62.11 | |
Ocera Therapeutics | 0.3 | $613k | 125k | 4.90 | |
Heron Therapeutics (HRTX) | 0.3 | $583k | 70k | 8.33 | |
Lipocine | 0.3 | $561k | 92k | 6.11 | |
Assembly Biosciences | 0.3 | $532k | 65k | 8.18 | |
pSivida | 0.2 | $442k | 100k | 4.42 | |
Unilife US | 0.2 | $344k | 150k | 2.29 | |
Catalyst Pharm Partners | 0.2 | $332k | 100k | 3.32 | |
Wright Med Group Inc right 03/01/2019 | 0.2 | $288k | 134k | 2.15 | |
Amarin Corporation (AMRN) | 0.1 | $218k | 200k | 1.09 | |
Flexion Therapeutics | 0.1 | $228k | 13k | 18.26 |